Position in VCYT
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$6,868,267
-$2,019,506 QoQ
Shares Held
213,234
+1.0% QoQ
Ownership
0.267%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 44%
Shared 0%
None 56%
Common Shares in VCYT Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026RHUMBLINE ADVISERS holds $1,136,235,129 across 32 Diagnostics & Research names. VCYT ranks #19 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
611,950 | $300,791,783 | |
| 2 | DHR |
Danaher Corp /De/
|
1,012,199 | $191,912,930 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
173,731 | $97,617,711 | |
| 4 | ILMN |
Illumina, Inc.
|
609,802 | $75,164,194 | |
| 5 | A |
Agilent Technologies, Inc.
|
499,389 | $56,920,358 | |
| 6 | IQV |
Iqvia Holdings Inc.
|
324,104 | $55,272,696 | |
| 7 | WAT |
Waters Corp /De/
|
178,037 | $53,019,418 | |
| 8 | MTD |
Mettler Toledo International Inc/
|
42,022 | $52,998,146 |
All Filings in VCYT
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,868,267 | 213,234 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $8,887,773 | 211,111 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $7,628,194 | 222,202 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $3,231,409 | 119,549 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $3,571,461 | 120,454 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $4,883,630 | 123,324 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $4,174,971 | 122,649 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $2,790,532 | 128,774 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $2,674,224 | 120,678 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $3,244,309 | 117,932 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $2,643,403 | 118,379 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $2,968,426 | 116,546 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $2,606,089 | 116,865 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $2,728,095 | 114,964 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,850,169 | 111,456 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $2,095,609 | 105,307 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $2,452,930 | 88,971 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $3,975,017 | 96,481 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $4,534,913 | 97,630 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $3,824,966 | 95,672 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $3,745,515 | 69,684 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $3,432,504 | 70,137 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $2,138,101 | 65,808 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,870,005 | 72,201 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,570,790 | 64,615 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||